/
BIOCQ
$0.00+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.10
0% from low
Exchange
OTC Link
CS
Price (6 mo)
Loading chart…
Change$-0.36
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Revenue | $5.5M | $27.5M | $61.2M | $25.9M |
| Cost of revenue | $11.0M | $21.3M | $37.8M | $28.4M |
| Gross profit | −$5.4M | $6.1M | $23.5M | −$2.6M |
| Gross margin | -98.6% | 22.3% | 38.3% | -10.0% |
| R&D | $4.7M | $5.2M | $5.0M | $6.2M |
| Operating income | −$23.1M | −$15.5M | −$2.4M | −$32.0M |
| EBITDA | −$24.1M | −$16.6M | −$879.0K | −$30.2M |
| Net income | −$25.1M | −$17.8M | −$2.8M | −$32.1M |
| Net margin | -454.7% | -64.8% | -4.6% | -124.1% |
| EPS (diluted) | -365.01 | -45.10 | -5.73 | -56.78 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $45M | $-0.10 | $-0.10–$-0.10 | 1 |
| 2027 | $90M | $1.61 | $1.61–$1.61 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
BIOCEPT INC
BIOCEPT INC
Held by traders on TradeandTell
No one on the platform currently holds BIOCQ.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BIOCQ as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded BIOCQ yet.
